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Background/aim: Tinnitus is seen in 15% of the general population; in 1%–6% of this number, the quality of life is seriously affected
by this chronic condition. Chemical, oxidative, and emotional stressors are important in terms of the clinical course of tinnitus. Apelin
is an endogenous peptide which is an oxidative stress mediator. It has been shown that the apelin/APJ (apelin junction receptor) system
plays various roles in the physiology and pathophysiology of many organs. However, the role of the apelin/APJ system as an oxidative
stress mediator in tinnitus is unknown. We investigated the level of apelin in patients with normal hearing and bilateral tinnitus.
Materials and methods: We enrolled patients diagnosed with bilateral idiopathic tinnitus. Tinnitus severity was determined using the
tinnitus handicap inventory (THI). We recorded the levels of plasma apelin-13 and biochemical parameters.
Results: The mean apelin level of the control group was higher than that of the patient group (P = 0.002). A significant negative
correlation was evident between the apelin level and the THI (r = –0.460, P = 0.003). The triglyceride (TG) level was significantly higher
in the patient group than in the control group (P < 0.001).
Conclusions: In our study, we found a negative correlation between apelin and tinnitus severity. Thus, apelin may play a role in the
pathophysiology of idiopathic tinnitus, and may be prescribed during follow-up to reduce oxidative stress in the future. Further clinical
studies on the effects of the apelin/APJ (apelin junction receptor) system and the effects of antioxidants in patients with inflammatory
diseases are required.
Key words: Apelin, oxidative stress, tinnitus

1. Introduction
Tinnitus, which affects 15% of the general population, is
the perception of imagined sound in the absence of an
external stimulus (1); the condition is most prevalent in
males aged 40–70 years. Tinnitus alone is not a clinical
sign; tinnitus is a symptom of several diseases. Tinnitus
becomes chronic in 1%–6% of patients and seriously
reduces quality of life. In addition, tinnitus-related factors
such as hearing loss, hypertension, hormonal disorders,
anxiety, depression, sleep disorders, and concentration
problems are more often encountered than tinnitus per
se (2). Nowadays, etiopathogenesis is still unclear in
50%–60% of patients who have tinnitus (1). Hearing
loss, acoustic trauma, Meniere’s disease, vestibular
schwannoma, temporomandibular joint disease, and the
use of otoacoustic drugs trigger tinnitus associated with
impaired otological functioning. In addition, metabolic,
neurogenic, or psychogenic disorders, environmental
factors, stress, or obesity may cause tinnitus (3).

Stress is important in terms of the clinical course of
tinnitus. Hearing is particularly sensitive to chemical,
oxidative, and emotional stressors (4). Apelin (a hormone)
mediates oxidative stress, and is expressed by the vascular
endothelium and adipose tissue. The aim of this study was
to investigate the apelin mediator as a new oxidative stress
parameter in tinnitus patients.
In 1993, O’Down et al. discovered a gene encoding
a 380-amino acid protein similar in sequence to the
angiotensin II type I receptor gene (5). The gene was
termed APJ (the apelin receptor) and, in 1998, Tatemato et
al. showed that apelin was the endogenous ligand (6). APJ
is a member of the G-protein-binding receptor family, all
members of which have 7 transmembrane regions. APJ is
encoded in the Xq25-26.1 region. A preproapelin protein of
77 amino acids is initially synthesized and then fragmented
into peptides with varying numbers of amino acids (e.g.,
apelin-10, -11, -12, -13, -15, -17, -19, and -36). Apelin-13 is
the primary active isoform, binding specifically to APJ (7).
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Apelin vasoconstricts damaged vessels, and thus serves
as an indicator of the severity of coronary artery stenosis
(8). If apelin, which is abundant in vessel endothelium,
plays a role during oxidative ear stress, and if tinnitus
were affected by apelin, apelin might exert protective and
therapeutic effects.
2. Materials and methods
The study was approved by the Clinical Research Ethics
Committee of Antalya Training and Research Hospital.
Informed consent was obtained from all patients and
controls. No subject had diabetes, dyslipidemia, or
cardiovascular disease. We included 40 patients aged >18
years with bilateral idiopathic tinnitus, no ear pathology,
and normal hearing. Tinnitus severity was determined
using the THI; the scores range from 0–16 points: mild
(only evident in a silent environment), 18–36: fair (easily
masked by surrounding noise and easily forgotten
during activity), 38–56: moderate (despite awareness of
background noise, daily activities can still be performed),
58–76: severe (present almost always, disrupting sleep
and daily activities), and 78–100: catastrophic (present
always, disrupting sleep and daily activities). The control
group contained 40 healthy volunteers aged >18 years with
normal ears and no tinnitus.
For all subjects, 10-mL amounts of fasting venous
blood were collected and plasma apelin levels assayed via
ELISA. Blood samples were immediately centrifuged for
20 min at 4000 rpm and stored at –80 °C. We used a human
AP 13 ELISA kit (range: 0.77–200 pg/mL, sensitivity:
0.658 pg/mL) (Sunred Biotechnology, Shanghai, China)
and a fully automatic MicroELISA device (Triturus/
Grifols, Barcelona, Spain). We also measured the levels of
fasting glucose (GLU), alanine aminotransferase (ALT),
aspartate aminotransferase (AST), blood urea nitrogen
(BUN), creatinine, triglycerides (TG), low-density
lipoprotein (LDL), high-density lipoprotein (HDL), total
cholesterol, hemoglobin (Hb), and hemoglobin A1c (Hb
A1c) employing the Beckman–Coulter au5800 and LH
780 platforms.
2.1. Statistical analysis
Statistical analyses were performed with the aid of IBM
SPSS Statistics for Windows version 23.0 (IBM Corp.,
Armonk, NY, USA). Categorical variables were compared
via Pearson chi-square testing. The normalities of betweengroup differences were assessed using the Shapiro–Wilk
test. The Mann–Whitney U-test and Student’s t-test
were employed to analyze nonnormally and normally
distributed numerical data, respectively. Spearman rank
correlation or Pearson correlation analyses were used
to explore the association of apelin levels with various
biochemical factors and the THI. The results are expressed
as numbers (n) with percentages (%), means ±standard

770

deviations (SDs), or medians (minima minus maxima).
A P-value <0.05 was considered to reflect statistical
significance.
3. Results
Gender distribution did not differ significantly between
patients and controls (P = 0.478). No significant betweengroup difference was evident in any biochemical parameter
(aSpearman rank correlation, bPearson correlation) (all P >
0.05).
The comparisons between apelin levels and biochemical
parameters in both groups are shown in the Table. In the
subgroup analysis, the serum apelin levels of the tinnitus
patients were significantly lower than those of the control
group (96.7 [34.5–152] pg/mL vs 122.6 [52.1–236] pg/
mL; P = 0.002) (Figure 1), as was the mean HDL level (P =
0.036). The TG level was significantly higher in the patient
group than in the control group (111.5 [37–351] mg/dl vs
90 [34–178] mg/dl; P < 0.001). There was no significant
correlation between biochemical parameters and apelin
levels in either group (P > 0.05). A significant negative
correlation was evident between the apelin level and the
THI (r = –0.460, P = 0.003; Figure 2). It was determined
that THI decreased when apelin level increased.
4. Discussion
Apelin-13 is the active isoform of apelin and binds to APJ
(7). In humans, the apelin plasma level is 89.8 ± 5.3 pg/mL
(9) and the circulatory halflife approximately 8 min (10).
However, Kawamata et al. found that the plasma apelin
concentration was lower than that of tissues, suggesting
that apelin might be both a circulatory endocrine factor
and a paracrine neurotransmitter (11).
Apelin is a ligand of the G-protein binding receptor
APJ, triggering various biological effects. Apelin/APJ
signaling plays recognized roles during vasodilation of
healthy endothelium, and also during vasoconstriction
after vascular endothelial damage (12). The APJ system
mediates oxidative stress in vascular tissue (13). Tatemato
et al. reported that apelin regulated endothelial nitric oxide
(NO) synthesis, increasing NO production. Apelin strongly
vasodilated vessels and exerted positive inotropic effects
on the heart (14). Yanga et al. showed that, during cerebral
ischemia/reperfusion, both apelin-13 and -36 protected
neurons from injury caused by neuroinflammation (15).
Apelin heals ischemic strokes by inhibiting cell death
and increasing angiogenesis. Oxidative stress associated
with ischemia/reperfusion injury is reduced by increases
in the activities of antioxidant enzymes such as superoxide
dismutase, catalase, and kidney glutathione peroxidase
(16). In an animal study, Chen et al. found that intranasal
apelin was a useful stroke treatment (17). The apelin/
APJ system regulated insulin sensitivity, gastrointestinal
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Table. The apelin levels and biochemical parameters of the patient and control groups.
Control (n: 40)

Patient (n: 40)

Mean ± SD

Median
(min–max)

Mean ± SD

Median
(min–max)

P

Apelin

122.7 ± 44.6

122.6 (521–236)

95.5 ± 31.1

96.7 (34.5–152)

0.002a

Glucose

93.6 ± 8

91.5 (83–118)

92.6 ± 9.3

90 (75–111)

0.671b

HbA1c

5.3 ± 0.3

5.2 (4.8–5.9)

5.4 ± 0.5

5.2 (4.6–6.4)

0.539b

BUN

12.6 ± 3.4

12 (8–23)

13.9 ± 3.5

14 (8–23)

0.097a

Creatinine

0.9 ± 0.1

0.9 (0.7–1.3)

0.9 ± 0.2

0.9 (0.6–1.4)

0.443b

ALT

16.8 ± 5.9

15 (8–35)

17.2 ± 6.1

16 (11–40)

0.746b

AST

18.5 ± 4.7

18 (12–35)

19.4 ± 3.7

18.5 (14–30)

0.147b

cholesterol

189.1 ± 21.8

197.5 (140–233)

187 ± 35.6

184 (125–277)

0.620b

HDL

58.9 ± 11.6

58.5 (30–91)

54 ± 8.8

53 (41–76)

0.036a

LDL

122.5 ± 25.4

114 (80–200)

125.6 ± 30.5

125.5 (66–200)

0.336b

TG

95.2 ± 30.4

90 (34–178)

130.2 ± 54.9

111.5 (37–351)

<0.001b

Hemoglobin

14 ± 1.2

13.7 (12.1–17.4)

13.8 ± 1.4

13.5 (10.1–16.9)

0.350b

a: Student’s t-test; b. Mann–Whitney U test.

Figure 1. The apelin levels of the 2 groups.

function, angiogenesis, and immune function, enhancing
cell migration and proliferation (13). It has been shown that
the apelin/APJ system plays various roles in the physiology
and pathophysiology of many organs, including regulation
of blood pressure, cardiac contractility, angiogenesis,
metabolic balance, and cell proliferation, inflammation,
or apoptosis. Oxidative stress is considered one of the
molecular factors in the pathogenesis of tinnitus (18,19).

However, the role of apelin/the APJ system as an oxidative
stress mediator in tinnitus is still unknown. The aim of
this study was to investigate the apelin mediator as a new
oxidative stress parameter in tinnitus patients.
Free radicals damage DNA, proteins, membranes, and
intracellular functions, playing roles in the development
of atherosclerosis, inflammation, and vascular damage.
Neri et al. reported that the plasma levels of oxidative
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Figure 2. Correlations between the apelin levels and the THIs.

stress markers were significantly elevated in patients
with idiopathic tinnitus (18). Oxidative stress increased
free radical levels in the labyrinth and the auditory and
vestibular pathways, triggering apoptosis of auditory
neurons and ciliary cells. Injection into the semicircular
canals of materials countering oxidative stress protected
the endolymph, neuromediator expression, and bioelectric
activity (18,19,20).
Antioxidants such as N-acetyl cysteine and magnesium
prevent oxidative stress, which plays a critical role in
the pathogenesis of noise-induced hearing loss and
tinnitus preventing apoptosis and cellular necrosis (20).
We found that as tinnitus severity increased, the apelin
level decreased. Apelin may inhibit the oxidative stress
associated with the pathophysiology of idiopathic tinnitus.
To the best of our knowledge, this is the first study to
explore the relationship between plasma apelin level and
tinnitus.

5. Conclusion
This is the first pilot study to explore the relationship between
the plasma apelin level and tinnitus. As tinnitus severity
increased, the apelin level fell. Thus, apelin may be an
independent risk factor in the pathophysiology of idiopathic
tinnitus, and may be prescribed during follow-up to reduce
oxidative stress in the future. The apelin/apelin receptor
(APJ) system may serve as a new therapeutic target in patients
with inflammatory diseases associated with oxidative stress,
which plays a role in the pathogenesis of inner ear ototoxic
lesions. Antioxidants protect reactive cochlear cells. Further
clinical studies on the effects of the apelin/APJ system, the
role played by oxidative stress, and the effects of antioxidants
in patients with inflammatory diseases are required.
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